This Government Contract opportunity from Department Of Defense was posted on May 1, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Synthetic Plasma Component Development
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The contract involves the development of a synthetic plasma matrix designed to replicate the volume-expanding, colloidal, and biochemical functions of human plasma. The product must ensure shelf stability and demonstrate compatibility with other biosynthetic components, which suggests a focus on both functional efficacy and practical usability in medical or defense applications. The work is being conducted as a subcontract under the Defense Advanced Research Projects Agency (DARPA) within the Department of Defense, indicating a high level of strategic importance and potential use in advanced biomedical research or field applications. This initiative falls under the NAICS code 325414, which relates to pharmaceuticals and medicine manufacturing, highlighting the technical and innovative nature of the project. The solicitation was posted on May 1, 2026, with responses due by May 19, 2026, reflecting a concise timeline for proposals. Although specific geographic or organizational details are not provided, the project’s placement within DARPA underscores its connection to national security priorities and the drive to develop cutting-edge synthetic biological materials.
General Info
Agency
NAICS
Place of Performance
VASet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Submission Closed
